Company Profile
ADMA Biologics Stock Price, News & Analysis
- Ticker:
- ADMA
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
8.48 USD (+2.54%)
Close
Last updated: July 27, 2026
1.76B USD
Market cap
Why the stock is moving
As of Jul 27, 2026, ADMA closed up 2.54% at $8.48. No new same-company headline was identified in the current news window.
Company overview
Business overview
ADMA Biologics is a plasma-derived biologics company focused on immunoglobulin therapies and specialty immune products. Its business is centered on plasma supply, manufacturing, and commercial execution.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, ADMA sits in biologics manufacturing and specialty plasma products.
Business Model Characteristics
The company depends on plasma collection, product sales, and manufacturing discipline across its immunoglobulin franchise.
Position Within the Biotechnology Landscape
ADMA is a biologics company with a commercial and manufacturing profile rather than a classic discovery-stage biotech profile.
Future catalysts
ADMA Biologics's catalysts are ASCENIV, BIVIGAM, and plasma-product manufacturing execution, with the stock mostly following commercial scale and supply discipline. The company moves on reliable commercialization more than on binary news.
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
- 02
Viðskipti stjórnenda og tengdra aðila
ALVO · Source: Alvotech
- 03
Transactions of Managers and Closely Associated Persons
ALVO · Source: Alvotech
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of ADMA Biologics (ADMA)?
ADMA Biologics (ADMA) most recently closed at 8.48 USD, a +2.54% move versus the previous session.
What is the market cap of ADMA Biologics (ADMA)?
ADMA Biologics currently has a market capitalization of 1.76B USD on BioPharmSignal.
What does ADMA Biologics do?
ADMA Biologics is a plasma-derived biologics company focused on immunoglobulin therapies and specialty immune products. Its business is centered on plasma supply, manufacturing, and commercial execution.
On which exchange is ADMA stock listed?
ADMA Biologics (ADMA) is associated with NASDAQ, United States, Biopharma.
What is Biologics?
ADMA Biologics's catalysts are ASCENIV, BIVIGAM, and plasma-product manufacturing execution, with the stock mostly following commercial scale and supply discipline.
Which conditions is ADMA Biologics targeting with Biologics?
ADMA Biologics's catalysts are ASCENIV, BIVIGAM, and plasma-product manufacturing execution, with the stock mostly following commercial scale and supply discipline.
How does ADMA Biologics describe recent progress with Biologics?
ADMA Biologics's catalysts are ASCENIV, BIVIGAM, and plasma-product manufacturing execution, with the stock mostly following commercial scale and supply discipline.
What future catalysts are investors watching for ADMA Biologics?
ADMA Biologics's catalysts are ASCENIV, BIVIGAM, and plasma-product manufacturing execution, with the stock mostly following commercial scale and supply discipline. The company moves on reliable commercialization more than on binary news.